
Request Appointment
161 Fort Washington AvenueFloor Hip 8New York, NY 10032
Overview of Dr. Moy
Dr. Ryan Moy is an internist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 1 year. He is one of 1129 doctors at New York-Presbyterian Hospital and one of 426 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Internal Medicine. He has more than 20 publications and over 500 citings.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2017 - 2021
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2015 - 2017
- Perelman School of Medicine at the University of PennsylvaniaClass of 2015
Certifications & Licensure
- FL State Medical License 2022 - Present
- NY State Medical License 2017 - 2026
- NJ State Medical License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- K08 NIH/NCI
- Robert Black Fellow Award Damon Runyon Cancer Research Foundation, 2019-2021
Publications & Presentations
PubMed
- Strengthening Asian/Asian American, Native Hawaiian, and Pacific Islander Leadership in Cancer Research.Lawrence W Wu, Ryan H Moy,
Cancer Discovery. 2025-02-07 - The complex interplay of antibiotic use and immune checkpoint inhibition.Lawrence W Wu, Ryan H Moy
The Oncologist. 2025-02-06 - Phase I trial of ATR inhibitor elimusertib with FOLFIRI in advanced or metastatic gastrointestinal malignancies (ETCTN 10406).Anuradha Krishnamurthy, Hong Wang, John C Rhee, Diwakar Davar, Ryan H Moy
Cancer Chemotherapy and Pharmacology. 2025-01-22
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: